AGP Picks
View all

California Health Watch
Provided by AGP

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 4, 2026

Cellectis to Report First Quarter Financial Results on May 11, 2026
May 4, 2026

Cellectis to Report First Quarter Financial Results on May 11, 2026

Indeterminate GlobeNewswire
Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026
May 4, 2026

Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026

Indeterminate GlobeNewswire
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 4, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
May 4, 2026

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Jushi Holdings Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
May 4, 2026

Jushi Holdings Inc. to Report First Quarter 2026 Financial Results on May 12, 2026

Indeterminate GlobeNewswire
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program
May 4, 2026

Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program

Indeterminate GlobeNewswire
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
May 4, 2026

Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

Indeterminate GlobeNewswire
BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026
May 4, 2026

BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026

Indeterminate GlobeNewswire
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
May 4, 2026

CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

Indeterminate GlobeNewswire
REGIONAL HEALTH PROPERTIES ANNOUNCES APPOINTMENT OF MARLIE DAVIS AS CHIEF FINANCIAL OFFICER
May 4, 2026

REGIONAL HEALTH PROPERTIES ANNOUNCES APPOINTMENT OF MARLIE DAVIS AS CHIEF FINANCIAL OFFICER

Indeterminate GlobeNewswire
AI Therapy 2026 Report Shows Holistic Shift; Therapy-Chats.com Goes Beyond AI Apps, According to BlockchainzTech
May 4, 2026

AI Therapy 2026 Report Shows Holistic Shift; Therapy-Chats.com Goes Beyond AI Apps, According to BlockchainzTech

Indeterminate EIN Presswire
Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
May 4, 2026

Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

Indeterminate GlobeNewswire
CooperCompanies Appoints Paul Keel to its Board of Directors
May 4, 2026

CooperCompanies Appoints Paul Keel to its Board of Directors

Indeterminate GlobeNewswire
InspireMD Reports First Quarter 2026 Financial Results
May 4, 2026

InspireMD Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Option Care Health to Participate in the Bank of America Health Care Conference
May 4, 2026

Option Care Health to Participate in the Bank of America Health Care Conference

Indeterminate GlobeNewswire
Kyntra Bio to Report First Quarter 2026 Financial Results
May 4, 2026

Kyntra Bio to Report First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12
May 4, 2026

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

Indeterminate GlobeNewswire
Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
May 4, 2026

Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital

Indeterminate GlobeNewswire
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
May 4, 2026

Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Indeterminate GlobeNewswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 4, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.